Semaphorin 3F expression is reduced in pregnancy complicated by preeclampsia. An observational clinical study

BACKGROUND AND OBJECTIVE: Preeclampsia is a systemic disorder, affecting 2–10% of pregnancies, characterized by a deregulated pro- and anti-angiogenic balance. Semaphorin 3F is an angiogenesis inhibitor. We aimed to investigate whether semaphorin 3F expression is modulated in preeclampsia. DESIGN, S...

Descripción completa

Detalles Bibliográficos
Autores principales: Stallone, Giovanni, Matteo, Maria, Netti, Giuseppe Stefano, Infante, Barbara, Di Lorenzo, Adelaide, Prattichizzo, Clelia, Carlucci, Stefania, Trezza, Federica, Gesualdo, Loreto, Greco, Pantaleo, Grandaliano, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5370113/
https://www.ncbi.nlm.nih.gov/pubmed/28350837
http://dx.doi.org/10.1371/journal.pone.0174400

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5370113/
https://www.ncbi.nlm.nih.gov/pubmed/28350837
http://dx.doi.org/10.1371/journal.pone.0174400

Ejemplares similares